Remove gsk-launches-shingles-vaccine-shingrix-in-india
article thumbnail

GSK launches shingles vaccine, Shingrix in India

Express Pharma

GlaxoSmithKline Pharmaceuticals (GSK) announced the launch of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) in India, for the prevention of shingles (herpes zoster) and post-herpetic neuralgia in adults aged 50 years and above. Shingles cause a painful rash.